Jump to Navigation

Pharmaceutical Litigation

Stopping the Harm Caused by Bad Drugs

It happens over and over again. A big pharmaceutical company puts a new drug on the market, advertises its benefits and rakes in the profits. When patients begin having adverse reactions, it turns out the drug company already knew about the problems.

The pharmaceutical litigation attorneys at Girardi | Keese want to put a stop to this practice of choosing profits over the health and welfare of patients. That is why we were the first law firm to file litigation against Vioxx. That is why pharmaceutical litigation is a top priority among our lawyers.

For more information about defective drug litigation, contact us or visit our pharmaceutical website.

Dangerous prescription drugs cause serious injury and death.

Unsafe medications can cause heart attacks, stroke, pancreatitis, pulmonary embolism, disintegrating jaw bones and other serious medical problems. Pharmaceutical litigation and the resulting multi-million-dollar verdicts are the only language drug manufacturers seem to understand. Current cases our lawyers are preparing for litigation include Avandia, Byetta, Yaz, Yasmin, gadolinium, Ortho Evra, Fosamax and HRT.

If you have questions about pharmaceutical litigation and the Girardi | Keese cases against drug companies, contact us. We represent clients injured by dangerous and defective drugs in California and nationwide.

Print this Page
GK Results

The law firm of Girardi | Keese has successfully recovered billions on behalf of our clients.
The following cases are just a small sampling of the many successful cases G&K has achieved over the years:

$4.85 billion

Settlement with Merck, a major pharmaceutical company, for personal injuries to consumers of the drug Vioxx.

$633 million

Settlements with PG&E for toxic tort injury claims by residents of Hinkley, California (made famous by the film Erin Brockovich).

$1.9 billion

Settlement with Sempra Energy on behalf of California consumers who were defrauded by the manipulation of natural gas prices.

See More GK Results

Privacy Policy | Law Firm Marketing by FindLaw, a Thomson Reuters business.

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close